AG 1321001SY

Drug Profile

AG 1321001SY

Alternative Names: AG-1321001SY

Latest Information Update: 21 Sep 2016

Price : $50

At a glance

  • Originator Ahn-Gook Pharmaceutical
  • Class Antitussives
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cough

Most Recent Events

  • 14 Sep 2016 Discontinued - Clinical-Phase-Unknown for Cough in South Korea (unspecified route)
  • 23 May 2016 Clinical trials in Cough in South Korea (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top